RENOVARO BIOSCIENCES

Renovaro Biosciences is developing a novel platform of therapeutic cancer vaccines using allogenic dendritic cells that are genetically engineered by design to bypass tumor immune response evasion and enhance tumor eradication. Dendritic cells are the professional antigen presenting cells in the body. Their role is to patrol our body, capture pathogens and to educate our immune system to recognize and eliminate unwanted cells and pathogens... We are a biotechnology company committed to developing advanced allogeneic cell and gene therapies to promote stronger immune system responses potentially for long-term or life-long cancer remission in some of the deadliest cancers, and potentially to treat or cure serious infectious diseases such as Human Immunodeficiency Virus (HIV) and Hepatitis B virus (HBV) infection.

Also known as: Renovaro Biosciences, Inc., Renovaro Inc.